Northern Trust’s iSpecimen ISPC Stock Holding History

Northern Trust’s Portfolio ISPC Stock Details ISPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-17	Closed	-$4.27K	–	4429
2024 Q2	$4.27K	Hold	17	–	–	﹤0.01%	4406
2024 Q1	$3.2K	Hold	17	–	–	﹤0.01%	4415
2023 Q4	$6.91K	Hold	17	–	–	﹤0.01%	4442
2023 Q3	$8.56K	Hold	17	–	–	﹤0.01%	4408
2023 Q2	$19.7K	Hold	17	–	–	﹤0.01%	4412
2023 Q1	$18.5K	Buy	+17	New	+$20.6K	﹤0.01%	4462

Other funds holding ISPC

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Northern Trust's ISPC Position: Q3 2024 in Review

Northern Trust sold out of iSpecimen (ISPC) in Q3 2024, closing a stake of 17 shares — an estimated $4.27K sold.

Northern Trust first reported a position in ISPC in Q1 2023 and held it in 6 quarters. The position peaked at $19.7K in Q2 2023. 6 funds tracked by Wall St. Rank hold ISPC as of Q3 2024.

Northern Trust reported no remaining iSpecimen position as of Q3 2024 after selling out during the quarter.
Northern Trust sold 17 iSpecimen shares in Q3 2024, an estimated $4.27K.
Northern Trust first reported a position in iSpecimen in Q1 2023 and held it in 6 quarters.
Northern Trust's iSpecimen position peaked at $19.7K in Q2 2023.
6 funds tracked by Wall St. Rank held iSpecimen as of Q3 2024.

Based on Northern Trust's 13F filing for Q3 2024, filed 13 Nov 2024.